Scholar Rock Holding Corporation
SRRK
Rank in Stocks
#3479
Scholar Rock Holding Corporation is a biopharmaceutical firm dedicated to... Scholar Rock Holding Corporation is a biopharmaceutical firm dedicated to discovering and advancing treatments for severe medical conditions by targeting the crucial role of protein growth factor signaling. Their lead therapeutic candidate, Apitegromab, an agent designed to inhibit the activation of latent myostatin, has successfully concluded Phase 3 clinical trials for spinal muscular atrophy (SMA). Another key program, SRK-181, is currently undergoing Phase 1 clinical assessment for tackling cancers that exhibit resistance to established checkpoint inhibitor treatments, including anti-PD-1 or anti-PD-L1 antibody therapies. Beyond these, the company cultivates a robust pipeline of innovative potential therapies, aiming to significantly improve the lives of individuals grappling with various severe ailments, such as neurological muscle conditions, malignancies, and fibrotic disorders. In a strategic partnership, Scholar Rock is collaborating with Gilead Sciences, Inc. to identify and develop targeted inhibitors of transforming growth factor beta (TGF-beta) activation, specifically for addressing fibrotic diseases. Established in 2012, Scholar Rock Holding Corporation operates from its headquarters in Cambridge, Massachusetts.
Share Price
$40.54
Last synced: 2026-10-19
Market Cap
$4.94B
Change (1 day)
1.59%
Change (1 year)
45.19%
Country
US
Trade Scholar Rock Holding Corporation (SRRK)
Category
Healthcare
Stock split history for Scholar Rock Holding Corporation (SRRK)
Scholar Rock Holding Corporation stock (symbol: SRRK) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 20, 2026.
One SRRK share bought prior to Oct 20, 2026 would equal to 0 SRRK shares today.
The most recent stock split occurred on Oct 20, 2026.
One SRRK share bought prior to Oct 20, 2026 would equal to 0 SRRK shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
